Valuation: Aspen Pharmacare Holdings Limited

Market Cap 70.36B 4.22B 3.75B 3.51B 3.2B 6.02B 406B 6.1B 42.42B 16.42B 207B 15.85B 15.5B 665B P/E 2026
26.3x
P/E 2027 * 14.5x
Enterprise Value 83.23B 4.99B 4.44B 4.15B 3.78B 7.12B 481B 7.21B 50.18B 19.42B 245B 18.75B 18.34B 786B EV / Sales 2026
-
EV / Sales 2027 * 1.83x
Free-Float
58.39%
Yield 2026
1.48%
Yield 2027 * 1.56%
1 day+0.07%
1 week-0.12%
Current month+0.07%
1 month+1.25%
3 months-0.06%
6 months+17.37%
Current year+35.67%
1 week 155.5
Extreme 155.5
162.5
1 month 144.22
Extreme 144.22
166.21
Current year 104.38
Extreme 104.38
166.21
1 year 90.7
Extreme 90.7
166.21
3 years 90.7
Extreme 90.7
252.96
5 years 90.7
Extreme 90.7
271.48
10 years 64.07
Extreme 64.07
327.5
Manager TitleAgeSince
Chief Executive Officer 62 1996-12-31
Director of Finance/CFO 61 2008-12-31
Chief Operating Officer 63 1998-12-31
Director TitleAgeSince
Director/Board Member 62 1998-12-31
Director/Board Member 65 1998-12-31
Chairman 58 2015-12-06
Date Insider Type Main position Quantity % Market Cap. Importance
9/27/23 Free

Chief Operating Officer

12,236 0.0027%
9/27/23 Free

Executive/Senior Manager

11,728 0.0026%
9/27/23 Free

Founder

10,558 0.0024%
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%-0.12%+66.44%-7.78% 4.22B
+0.51%-2.19%+41.19%+115.04% 1,025B
-0.38%-5.23%+38.20%+65.67% 623B
-0.09%-1.57%+9.99%+75.51% 459B
-0.03%-3.36%+60.63%+40.20% 355B
-0.44%-3.52%+22.27%+40.13% 336B
-1.37%-2.60%+12.17%+24.97% 270B
-0.91%-5.16%-4.42%+8.71% 247B
-0.47%-2.18%+36.37%+52.29% 220B
-0.77%-3.13%+32.24%+97.31% 183B
Average -0.33%-1.61%+31.51%+51.21% 372.24B
Weighted average by Cap. -0.14%-2.10%+31.16%+69.70%

Financials

2026 2027 *
Net sales 37.62B 2.26B 2B 1.87B 1.71B 3.22B 217B 3.26B 22.68B 8.78B 111B 8.47B 8.29B 355B 37.04B 2.22B 1.97B 1.85B 1.68B 3.17B 214B 3.21B 22.33B 8.64B 109B 8.34B 8.16B 350B
Net income 4.8B 288M 256M 239M 218M 410M 27.72B 416M 2.89B 1.12B 14.12B 1.08B 1.06B 45.34B 4.77B 286M 254M 238M 217M 408M 27.55B 413M 2.88B 1.11B 14.03B 1.07B 1.05B 45.07B
Net Debt 12.88B 773M 686M 642M 585M 1.1B 74.39B 1.12B 7.76B 3.01B 37.88B 2.9B 2.84B 122B -2.41B -145M -129M -120M -110M -206M -13.94B -209M -1.46B -563M -7.1B -544M -532M -22.81B
Logo Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows: - pharmaceuticals (68.4%): anaesthetics products, thrombosis products, cytotoxic products, etc.; - other (31.6%): infant nutrition products and consumer products. At the end of June 2024, the group had 24 production sites worldwide.
Employees
9,343
Date Price Change Volume
26-10-01 ZAR 158.45 +0.07% 1,049,510
26-09-30 ZAR 158.34 -1.65% 969,817
26-09-29 ZAR 161.00 +1.11% 1,347,619
26-09-28 ZAR 159.23 +1.41% 997,347
26-09-25 ZAR 157.01 -1.03% 1,220,299
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
158.45ZAR
Average target price
172.67ZAR
Spread / Average Target
+8.97%

Annual profits - Rate of surprise